Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 110 | 1 | 108 | −1 |
| Shares | 37.2M | 28.5K | 39.5M | +2.30M (+6.2%) |
| Value | $657.3M | $504.0K | $929.9M | +$273.2M (+41.6%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 3,453,371 | $81.7M | 8.23% |
| Paradigm Biocapital Advisors LP | 212,961 | $5.04M | 1.33% |
| Opaleye Management Inc. | 136,000 | $3.22M | 1.00% |
| First Manhattan Co | 116,622 | $2.76M | 0.01% |
| Norges Bank | 87,100 | $2.06M | 0.00% |
| Fred Alger Management, LLC | 48,921 | $1.16M | 0.00% |
| Barclays PLC | 23,380 | $553.0K | 0.00% |
| Simplex Trading, LLC | 16,627 | $393.0K | 0.01% |
| UBS Asset Management Americas Inc | 14,800 | $350.0K | 0.00% |
| Victory Capital Management Inc | 28,907 | $278.0K | 0.00% |
| Corton Capital Inc. | 9,912 | $234.0K | 0.10% |
| Blackstone Group Inc. | 9,500 | $225.0K | 0.00% |
| Belvedere Trading LLC | 15,785 | $201.0K | 0.14% |
| Quantbot Technologies LP | 4,600 | $108.0K | 0.01% |
| Caption Management, LLC | 4,187 | $99.0K | 0.01% |
| Amalgamated Bank | 3,324 | $79.0K | 0.00% |
| Amalgamated Financial Corp. | 3,324 | $79.0K | 0.00% |
| US Bancorp | 790 | $19.0K | 0.00% |
| Lindbrook Capital, LLC | 799 | $19.0K | 0.00% |
| Signaturefd, LLC | 254 | $6.00K | 0.00% |
| Quadrant Capital Group LLC | 92 | $2.00K | 0.00% |
Sold out (22)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Holocene Advisors, LP | 864,978 | $15.3M |
| Darwin Global Management, Ltd. | 317,428 | $5.62M |
| HighVista Strategies LLC | 89,963 | $1.59M |
| Allianz Asset Management GmbH | 75,525 | $1.33M |
| Millennium Management LLC | 58,375 | $1.03M |
| HarbourVest Partners LLC | 39,511 | $699.0K |
| Prudential Financial Inc | 28,770 | $509.0K |
| UNC Management Company, Inc. | 23,708 | $419.0K |
| Ergoteles LLC | 21,400 | $379.0K |
| Alpine Global Management, LLC | 20,905 | $370.0K |
| Old Mission Capital LLC | 20,670 | $366.0K |
| Gyon Technologies Capital Management, LP | 15,534 | $275.0K |
| AQR Capital Management LLC | 14,024 | $248.0K |
| Marshall Wace, LLP | 13,513 | $239.0K |
| Rafferty Asset Management, LLC | 12,971 | $229.0K |
| Balyasny Asset Management LLC | 11,734 | $208.0K |
| Boulder Hill Capital Management LP | 11,600 | $205.0K |
| Jump Financial, LLC | 10,882 | $193.0K |
| Hershey Trust Co | 7,903 | $140.0K |
| Point72 Hong Kong Ltd | 982 | $17.0K |
| State of Wyoming | 749 | $13.0K |
| Smith Group Asset Management, LLC | 520 | $9.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 28,500 | $504.0K |